search
insulin
Trends
- 1One Genetic Tweak Could Turn Pancreatic Cells Into Diabetes Treatment▼Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https:// fed.brid.gy/r/https://www.wire d.c
A new Wired report describes research suggesting certain pancreatic cells are only a single genetic modification away from becoming insulin-producing cells, a potential route to treating diabetes. Scientists say the finding could open new regenerative approaches, though the work remains at an early stage and clinical applications are likely years away.
- 2The End of Insulin Injections? Scientists Pursue Needle-Free Medicine▼The End of Insulin Injections? How Scientists Are Making Medicine Needle-Free
National Geographic reports on scientific efforts to replace insulin injections with needle-free alternatives, a change that could affect millions of people with diabetes who rely on daily injections. Researchers are exploring new delivery methods that would remove the need for needles in administering insulin and potentially other medicines.
- 3Israeli startup DreaMed wins FDA nod for insulin-dosing app▼Israeli startup DreaMed gets FDA approval for app that adjusts insulin doses for Type 2 diabetes
Israeli medtech startup DreaMed Diabetes has received FDA approval for an app that automatically adjusts insulin doses for people with Type 2 diabetes. The clearance lets the company bring its digital insulin-management tool to American patients, extending technology previously aimed at Type 1 diabetes. The news, reported by Calcalist, is being read as a milestone for Israeli digital health firms seeking US market entry.
- 4Israeli startup wins FDA clearance for injection-based diabetes app▼Israeli startup develops injection-based diabetes app, receives FDA clearance
An Israeli startup has received FDA clearance for an app designed to support people who manage diabetes with insulin injections. The digital tool aims to help patients track and manage their injection-based treatment, and its clearance means it can now be marketed in the United States. The news was reported by The Jerusalem Post and highlights Israel's growing health-tech sector.
- 5FDA approves Onswik, a once-weekly insulin for type 2 diabetes●The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the s
The FDA has approved Onswik, a once-weekly insulin intended for adults with type 2 diabetes. It was not approved for type 1 diabetes. Coverage highlights what the clinical trials showed about effectiveness and the side effects patients should know about. The approval is drawing attention as a potential convenience shift for diabetes management, reducing injections from daily to weekly.